Venus Concept Inc.

Toronto, A6 · Founded 2021 · CIK 0001409269 · Medtech · Acquired

Aesthetic medical devices for skin treatment and body contouring

ir.venusconcept.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$196M
12 Form D · Apr 2026
6 months since last filing
Contracts
—
No federal contracts on record
Patents
2
2 granted · 0 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,999,999
Private capital raisedForm D · SEC$41,000,000
Private capital raisedForm D · SEC$45,208,699
Private capital raisedForm D · SEC$4,820,906
Private capital raisedForm D · SEC$23,884,821
Private capital raisedForm D · SEC$50,516,865
Private capital raised· 1 of 2 same dayForm D · SEC$12,260,523
Private capital raised· 2 of 2 same dayForm D · SEC$4,738,444
Private capital raisedForm D · SEC$6,720,000
Private capital raisedForm D · SEC$2,000,000
Private capital raisedForm D · SEC$1,095,783
Private capital raisedForm D · SEC$1,500,000
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1946CVRx, Inc.—$126M
1947Ivenix, Inc.—$84M
1948EXAGEN INC.—$85M
1949Venus Concept Inc.—$196M
1950KENTUCKY IMAGING TECHNOLOGIES, LLC——
1951Intact Vascular—$80M
1952BioIntelliSense, Inc.—$140M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 53 related persons
  • Avinash AminDirector
  • Richard BarryDirector
  • Scott BarryDirector · Executive Officer
  • Jeff BirdDirector
  • JEFF BIRDDirector
  • Emmett CunninghamDirector
  • Emmett Cunningham, Jr.Director
  • Domenic Della PennaExecutive Officer
  • Dominic Della PennaExecutive Officer
  • Rajiv De SilvaDirector · Executive Officer
  • Domenic Di SistoExecutive Officer
  • TOM FOGARTYDirector
  • Anna GeorgiadisExecutive Officer
  • Kirk GunhusExecutive Officer
  • Charlotte HollandExecutive Officer
  • S. HollmigDirector
  • Stanley HollmigDirector
  • Yoni IgerExecutive Officer
  • Melissa KangExecutive Officer
  • William KelleyExecutive Officer
  • Doug KellyDirector
  • DOUG KELLYDirector
  • GIL KILMANDirector
  • Gil KlimanDirector
  • Garheng KongDirector
  • Anat KotlerExecutive Officer
  • Louise LacchinDirector
  • Fritz LaPorteDirector
  • Ray LeeExecutive Officer
  • Michael MandarelloExecutive Officer
  • James McCollumDirector · Executive Officer
  • Jim McCollumDirector · Executive Officer
  • JIM MCCOLLUMDirector · Executive Officer
  • William McGrailExecutive Officer
  • Fred MollDirector
  • Frederic MollDirector
  • FRED MOLLDirector
  • Anthony NataleDirector
  • Brent NixonExecutive Officer
  • Domenic PennaExecutive Officer
  • Ross PortaroExecutive Officer
  • Cary RaymentDirector
  • Ryan RhodesDirector · Executive Officer
  • Domenic SerafinoDirector · Executive Officer
  • Soeren SinayExecutive Officer
  • Soren SinayExecutive Officer
  • Keith SullivanDirector
  • Juliet Tammenoms BakkerDirector
  • Craig TaylorDirector
  • Shelley ThunenDirector
  • Hemanth VargheseExecutive Officer
  • Boris VaynbergExecutive Officer
  • Gabriele ZingarettiExecutive Officer

Patents

USPTO · 2 granted of 2

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.